SOHO 2023 Eleventh Annual Meeting
C

Upfront Management of DLBCL

By SOHO 2023 Eleventh Annual Meeting FEATURING Christopher Flowers
By SOHO 2023 Eleventh Annual Meeting FEATURING Christopher Flowers
248 views
November 21, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

550 views
22:09

New Updates in Frontline DLBCL

Scripps Health

L. Nastoupil

704 views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

656 views
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

613 views
35:27

Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

699 views
04:04

Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial

Wojciech Jurczak

343 views
10:04

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

Tara Graff

477 views
08:01

Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC

Georg Lenz

287 views
30:07

Current Management of DLBCL From Frontline to Relapsed Disease

Dipenkumar Modi

325 views
06:07

Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLB…

Patrizia Mondello

174 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

304 views
35:24

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

SOHO Highlights: State of the Art and Next Questions

G. Nowakowski

395 views
33:48

State of the Art and Next Questions: B-Cell Lymphoma

SOHO Highlights: State of the Art and Next Questions

L. Nastoupil

428 views
34:36

Frontline DLBCL Treatment Approaches

MyCancerHaven

R. Vij, H. Cherng

314 views
22:35

Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL

Yale Cancer Center

T. Sethi

163 views
14:47

Bispecifics for LBCL: Guidance for Management of Toxicities in the C…

UChicago Medicine

J. Crombie

160 views
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

234 views
18:29

Considering Alternatives to CAR-T in R/R DLBCL

Julio Chavez

150 views
15:26

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Moffitt Cancer Center

A. Lazaryan

332 views
AUTOPLAY